CORE--CLINICAL AND LABORATORY
核心——临床和实验室
基本信息
- 批准号:6104725
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:Candida albicans Epstein Barr virus HIV infections biomedical facility biopsy candidiasis clinical research electron microscopy human subject immunocytochemistry in situ hybridization microorganism classification oral health oral leukoplakia oral pharyngeal disorder oral pharyngeal disorder diagnosis patient /disease registry tissue resource /registry
项目摘要
The dental and medical clinicians of the Clinical/Laboratory Core
will see all patients referred by the San Francisco epidemiology
cohorts and validate diagnoses. From these referrals and other
sources of patient referrals, they will continue to build
clinical cohorts of patients with specific oral lesions in order
to analyze their repationship to the development of AIDS and to
other markers/predictors. They will obtain biopsies and other
samples for the studies in Projects 2 and 3 from
well-characterized patients with the oral lesions being studied.
The core staff will be responsible for clinical research pateints
records, for speciment handling and storage and for getting
speciments to Projects 2 and 3 investigators. They will stain
smears and sections, handled samples and biopsy tissue
speciments, maintain pathology and other clinical laboratory
data, perform in situ hybridization for Epstein-Barr virus to
confirm the diagnosis of hairy leukoplakia. Projects 2 and 3
will be using Core B for transmission electron microscopy and
electron cytochemistry. The Clinical/Laboratory Core
investigators will continue to study the clinical and
pathological features of the oral manifestation of HIV infection
and, in conjunction with Project 1, 2 and 3 investigators, will
continue to report new features and to explore their etiology,
pathogenesis and response to therapy. Part of the
responsibilities of the investigators in the Cores and the
Projects will be to continue to document and publish such new
findings and to conceive and test new hypotheses concening this
fascinating and challenging group of diseases.
临床/实验室核心的牙科和医学临床医生
会看到旧金山流行病学杂志转介的所有患者
队列和验证诊断。从这些转介和其他
患者转诊来源,他们将继续建立
口腔特殊病变患者的临床队列排序
分析其与艾滋病发病的关系,并探讨其与艾滋病发病的关系
其他标记物/预测物。他们将得到活组织检查和其他
项目2和项目3的研究样本来自
具有良好特征的患者,口腔损害正在研究中。
核心工作人员将负责临床研究申请
记录,用于标本处理和存储以及获取
将标本交给项目2和项目3的调查人员。他们会弄脏的
涂片和切片、处理过的样本和活组织
标本,维持病理学和其他临床实验室
数据,进行EB病毒的原位杂交,以
确认毛状白斑的诊断。项目2和项目3
将使用内核B进行透射电子显微镜检查,
电子细胞化学。临床/实验室核心
调查人员将继续研究临床和
HIV感染口腔表现的病理学特征
并将与项目1、2和3调查人员一起,
继续报告新的特征并探索其病因,
发病机制和治疗反应。部分内容
核心调查人员的责任和
项目将继续记录和发布这种新的
发现,并设想和测试新的假设设想
一组令人着迷和具有挑战性的疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBORAH GREENSPAN其他文献
DEBORAH GREENSPAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBORAH GREENSPAN', 18)}}的其他基金
相似海外基金
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10889325 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
- 批准号:
10829620 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus
项目 4 - 控制 Epstein-Barr 病毒中的潜伏至裂解转换
- 批准号:
10910338 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
- 批准号:
10755205 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Regulation and Functions of the Epstein-Barr Virus Lytic Switch Protein
EB 病毒裂解开关蛋白的调控和功能
- 批准号:
489085 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
- 批准号:
10679118 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
- 批准号:
10755055 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
- 批准号:
10568864 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
项目 2:对 Epstein-Barr 病毒作为津巴布韦艾滋病毒感染者结膜鳞状细胞癌潜在原因的新调查
- 批准号:
10598376 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus
项目 3 - 描述 Epstein-Barr 病毒和卡波西肉瘤相关疱疹病毒的扩增工厂
- 批准号:
10910337 - 财政年份:2023
- 资助金额:
-- - 项目类别: